Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
8
NMRA Quote, Financials, Valuation and Earnings
Last price:
$0.68
Seasonality move
:
-29.59%
Day range:
$0.64 - $0.72
52-week range:
$0.62 - $17.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.38x
Volume:
880.7K
Avg. volume:
1.2M
1-year change:
-95.13%
Market cap:
$110.4M
Revenue:
--
EPS (TTM):
-$1.53
Earnings Data
Next earnings date for NMRA
May 07
2025
Most recent earnings per share
-$0.37
Beat by $0.07
(Mar 3/2025)
Consensus Estimate
-$0.44
(Mar 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NMRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.40 | -- |
| 05/07/2025 | Q1 | -- | -- | -- | -$0.38 | -- |
| 03/03/2025 | Q4 | -- | -- | -$0.37 | -$0.44 | $0.07 |
| 11/12/2024 | Q3 | -- | -- | -$0.45 | -$0.38 | -$0.07 |
| 08/06/2024 | Q2 | -- | -- | -$0.37 | -$0.36 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.34 | -$0.32 | -$0.02 |
| 03/07/2024 | Q4 | -- | -- | -$0.68 | -$0.60 | -$0.08 |
| 11/01/2023 | Q3 | -- | -- | -$1.14 | -$0.43 | -$0.71 |
| 06/30/2023 | Q2 | -- | -- | -$0.25 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.19 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.19 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.28 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.18 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$1.17 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.11 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
Neumora Therapeutics Earnings Questions
-
How Much did Neumora Therapeutics Generate in Revenue Last Quarter?
Neumora Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Neumora Therapeutics Beat Earnings Last Quarter?
Neumora Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.44 per share.
-
Is Neumora Therapeutics Profitable?
Neumora Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Neumora Therapeutics EPS Next Year?
Neumora Therapeutics's earnings are forecast to decrease from -$1.53 per share to -$1.52 per share next year representing a decrease of -0.56%.
-
When is Neumora Therapeutics's Earnings Date?
Neumora Therapeutics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
